With the support of
The ‘Ensuring Drug Security’ Russian Pharmaceutical Forum, the main business event of the pharmaceutical industry, will be held on 14 June, the opening day of the St. Petersburg International Economic Forum.
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
Timely provision of patients with safe, effective, and quality medication is an urgent matter for the Russian Government, the Russian Ministry of Health, and Roszdravnadzor. Public events where these issues are discussed are always interesting for both the government and the professional community. I am sure that the Drug Security Forum will become a discussion platform, where practical proposals for the development of the pharmaceutical industry will originate and new opportunities to improve the domestic industry for the benefit of Russian patients will be found.
The pandemic posed a serious challenge to the national drug delivery system. However, thanks to the new threat, we were able to come together as never before to respond quickly and find new solutions. Business and the government worked as a single coherent mechanism, and the pharmaceutical industry was almost instantly restructured to work more effectively under the new conditions. This is the first time the Drug Security Forum is taking place, but I am sure that meetings of the expert community on the sidelines of the Forum will become traditional, and the Forum itself will become a key business event of the industry.
Event formats that bring together representatives of state authorities, business, and professional associations must be used effectively at all stages of drug development. Negotiating process with patients, pharmaceutical industry, and government must be civilized. Decisions we make must be systematic and well thought out. I am sure that within the Drug Security Forum we will be able to outline further effective steps to regulate the national drug supply system.
The disappearance of life-saving drugs from the system is a huge challenge, which we must assess, analyze, and take certain steps to ensure that this does not happen again. In this case, we need to build a quality dialogue with the patient community, the people who are the main beneficiaries of drug security activities. This dialogue should be developed along the following guideline: "patient - patient organization - pharmaceutical manufacturer." In the end, patient organizations must participate in making regulatory decisions. The topic of patient-centred drug provision will be one of the key themes of the Drug Security Forum.
National security is what makes Russia independent from any outside pressure and enables it to develop independently. With people paying 200 million visits to dental clinics each year and more than 5,000 items used in dental practice, it is essential to create a full cycle of import substitution in dentistry to ensure Russian citizens can meet their needs for high-quality and uninterrupted dental treatment.
Each year, the ‘Ensuring Drug Security’ Forum demonstrates the need for specialists from the pharmaceutical business, doctors, and healthcare leaders to interact on a single discussion platform. Given the current need for import substitution and the regulation of drug circulation in Russia, documents that govern pharmaceutical and medical activities need to be harmonized. Exchanging opinions and experience as well as discussing controversial issues will help the Russian healthcare industry avoid any unnecessary procedural and regulatory obstacles in the development, research, and use of medicines
Healthcare is one of the three most popular topics in terms of the number of hits on the explain.rf and nationalprojects.rf portals. People are paying increased attention to such issues as affordable and high-quality medical care, including drug supply. In order for support measures to be sought-after and meet people’s current demands, regardless of age, individual needs, and geography, the government, society, and medical and business communities need to maintain an open dialogue. The Forum allows for organizing this specific format of interaction.
To bring together representatives of government, the pharmaceutical industry and civil society with the aim of developing strategies to improve medicine provision for all
To outline development pathways for regulation in medicine policy, based on partnership and strategic flexibility
To determine tools to ensure an uninterrupted supply of medicines and to make them accessible to patients
To develop patient-focused approaches and mechanisms that can help make innovative medicines available to all
To determine specific steps that should be taken to ensure national security in the field of medicine, with the aim of achieving self-sufficiency
With the support of
Subcommittee for drug circulation and the development of the pharmaceutical and medical industries (a body operating under the State Duma of the Russian Federation’s Health Protection Committee).
Organization partner
